NUS Nu Skin Enterprises, Inc. Common Stock
O Nu Skin Enterprises, Inc. Common Stock Przegląd firmy z Wikipedii
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
Czytaj więcej
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
History
In 1984, Nu Skin founders Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund launched a line of skincare products using only natural ingredients. The founders aimed to create skincare products and nutritional products without unnecessary fillers with the philosophy of “all of the good, none of the bad.”
The company first served the United States market and expanded operations to Canada in 1990. In 1991, the company began operations in Asia, starting in Hong Kong. In 1996, the company listed on the New York Stock Exchange.
In 1992, Nu Skin settled with five states that accused the company of deceptive advertising and overstating distributor income. In 1994, the company paid $1 million and signed a consent decree with the FTC prohibiting it from making deceptive product claims. In 1997, the company paid an additional $1.5 million to the FTC to settle allegations of unsubstantiated claims.
In 1998, Nu Skin acquired Generation Health, the parent company of the dietary supplement company Pharmanex. According to Women's Health Letter, the Pharmanex device was designed merely to help sell more supplements, since per Nu Skin's 2002 annual report, "as customers track their skin carotenoid content, we believe they will be motivated to consistently consume LifePak for longer periods of time."
In the late 1990s, Nu Skin invested in Big Planet, a multilevel marketing company selling Internet services. The New York Times wrote that Big Planet recruited people "even if they have little knowledge of the technology that they are supposed to be selling," with a Big Planet representative quoted: "I believe people who have never touched a computer before can become hugely wealthy in this business."
In 2009, Nu Skin began working with LifeGen Technologies, a genomics company based in Madison, Wisconsin. Nu Skin acquired LifeGen in December 2011. Nu Skin claims LifeGen's genetic database aided in the development of Nu Skin's products, launching the ageLOC brand.
In 2016, Nu Skin paid a $47 million class-action settlement, citing failure to disclose that its Chinese subsidiary did not register as the direct seller. Nu Skin paid $750k in fines to the United States Securities and Exchange Commission following allegations of a bribe that saw charity funds go to a Chinese politician.
In 2021, Nu Skin's subsidiary Rhyz Inc. acquired social commerce company Mavely and acquired Dallas-based skincare company BeautyBio in 2023. In 2025, the company sold the Mavely platform for five times what it paid for the company in 2021, in a $250 million transaction to Later, the Summit Partners company.
Products
Nu Skin was granted a patent on a device developed by Pharmanex called a "BioPhotonic Scanner", which is designed to measure the carotenoid level in skin. The company launched its ageLOC anti-aging brand in 2008.
In 2014, Nu Skin launched the Nu Skin Facial Spa which received FDA clearance for over-the-counter cosmetic use. In 2018, the company introduced the ageLOC LumiSpa, a dual-action skin care device that uses a soft silicone treatment head to gently cleanse away dirt, oil, and makeup.
Nu Skin launched ageLOC LumiSpa iO, the company's first connected device, in 2022. LumiSpa iO is a smart treatment and cleansing device for customized skin care, popularized by Venus Williams. Nu Skin launched Nu Colour “Lash + Brow” in 2023, marketed as free of prostaglandins. In 2022, Nu Skin launched a line of Nutricentials Bioadaptive Skin Care Pumps. In 2024, the company launched Nu Skin RenuSpa iO, an FDA-cleared microcurrent body device with a connected app to view live insights during treatment. RenuSpa iO is the company's first integrated beauty and wellness device. In 2024, Nu Skin launched MYND360 as a supplement and topicals product line for cognitive health.
Reception
Nu Skin Enterprises' is a multi-level marketing business. Each distributor markets products directly to potential customers and may also recruit and train customers to become distributors. Distributors are paid on the retail markup on products they are able to sell, as well as a performance bonus based on the sales of recruited distributors. In the early 1990s, Nu Skin was investigated by Connecticut, Pennsylvania, Florida, Illinois, Ohio, and Michigan over allegations of misleading marketing practices. In 1992 the company settled with five of the states, admitted no wrongdoing but agreed to pay the states' investigative costs, refund distributors, and revamp its promotional practices. The Connecticut Attorney General did not agree to those terms and sued Nu Skin, alleging the company misled its distributors and operated a pyramid scheme. Nu Skin admitted to no wrongdoing or violation of law and settled with the state for $85k for consumer-protection programs.
In 1997, the Attorney General of Pennsylvania alleged in a lawsuit that Nu Skin operated a pyramid scheme through a subsidiary, QIQ Connections and that distributors paid for the right to market technology services that did not, in fact, exist. Nu Skin discontinued the QIQ subsidiary, allowing those who had paid QIQ to move to Big Planet, a Nu Skin investment marketing Internet technology. The president of Big Planet described the allegations as a matter of "a few distributors who in their enthusiasm have been overzealous in some of their marketing activities."
In 2010, Nu Skin was listed among Forbes "100 Most Trustworthy Companies".
In 2011, two Utah-incorporated business entities linked to top executives of Nu Skin each made a $1 million contribution to Restore Our Future, a Super PAC established by former aides to U.S. presidential candidate Mitt Romney to support his bid for the White House.
In 2012, Stanford University apologized for an misunderstanding following a cease and desist letter sent to halt the use of the name of one of its researchers, Dr. Stuart Kim, in Nu Skin's advertising. Also in 2012, Citron Research issued a report "stating that Nu Skin's sales model on mainland China, the fastest growing market in direct-selling, amounted to an illegal multilevel marketing scheme." Nu Skin dismissed the claims, calling its sales model in China "kosher" and stating that it had no plans to change its business model. In 2014, The Chinese government investigated Nu Skin following a People's Daily newspaper report calling it a "suspected illegal pyramid scheme." Following the investigation, the Chinese government fined Nu Skin for $540k due to illegal sales and making false product claims.
In February 2014, a press release shows a class action lawsuit filed in the U.S. District Court for the District of Utah against Nu Skin Enterprises on behalf of investors who acquired stock of the company from July 2013, to January 2014.
In a Last Week Tonight with John Oliver segment that covered multilevel marketing companies, Oliver criticized Nu Skin for the fact that in 2015, 93% of its distributors did not earn a commission check in a typical month. Nu Skin says it pays approximately 43 percent of its product revenue in sales compensation.
In 2025, Nu Skin was named to USA Today's list of "best customer service."
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
NUS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
NUS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 29 maja 2026 | $0,0600 |
| 27 lutego 2026 | $0,0600 |
| 28 listopada 2025 | $0,0600 |
| 29 sierpnia 2025 | $0,0600 |
| 30 maja 2025 | $0,0600 |
| 24 lutego 2025 | $0,0600 |
| 29 listopada 2024 | $0,0600 |
| 30 sierpnia 2024 | $0,0600 |
| 31 maja 2024 | $0,0600 |
| 23 lutego 2024 | $0,0600 |
| 22 listopada 2023 | $0,3900 |
| 24 sierpnia 2023 | $0,3900 |
| 25 maja 2023 | $0,3900 |
| 24 lutego 2023 | $0,3900 |
| 23 listopada 2022 | $0,3850 |
| 25 sierpnia 2022 | $0,3850 |
| 26 maja 2022 | $0,3850 |
| 25 lutego 2022 | $0,3850 |
| 24 listopada 2021 | $0,3800 |
| 26 sierpnia 2021 | $0,3800 |
NUS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 0 0,0%
- Kup 0 0,0%
- Trzymaj 3 37,5%
- Sprzedaj 4 50,0%
- Mocna sprzedaż 1 12,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $0.20 | $0.20 | -0.00% |
| 31 marca 2026 | $0.14 | $0.15 | -0.01% |
| 31 grudnia 2025 | $0.29 | $0.30 | -0.01% |
| 30 września 2025 | $0.34 | $0.30 | 0.04% |
| 30 czerwca 2025 | $0.43 | $0.25 | 0.18% |
| 31 marca 2025 | $0.23 | $0.13 | 0.10% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| NUS | — | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| HNST | $291M | -18.4 | -1.9% | -4.2% | -8.8% | 33.3% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
| FTLF | — | 25.8 | 26.4% | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B | $2.25B | |
| Cost of Revenue | $454M | $550M | $612M | $631M | $675M | $658M | $581M | $634M | $502M | $500M | $490M | |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B | $1.76B | |
| R&D Expense | $11M | $13M | $23M | $23M | $27M | $23M | $30M | $23M | $22M | $24M | $20M | |
| SG&A Expense | $432M | $479M | $547M | $556M | $654M | $636M | $616M | $662M | $565M | $554M | $561M | |
| Operating Expenses | $966M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.80B | $1.50B | $1.48B | $1.51B | |
| Operating Income | $66M | $-152M | $48M | $111M | $234M | $258M | $267M | $241M | $274M | $231M | $245M | |
| Interest Expense | · | · | $26M | $14M | $11M | $13M | $19M | $22M | $22M | $16M | $8M | |
| Other Non-op | $-32M | $3M | $4M | $-8M | $-2M | $-1M | $-12M | $-21M | $-9M | $-18M | $-33M | |
| Pretax Income | $196M | $-175M | $27M | $89M | $232M | $256M | $255M | $220M | $266M | $213M | $212M | |
| Income Tax | $36M | $-28M | $18M | $-16M | $85M | $65M | $82M | $98M | $136M | $70M | $79M | |
| Net Income | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | $143M | $133M | |
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | |
| Shares (Basic) | 49,293,000 | 49,662,000 | 49,711,000 | 50,002,000 | 50,193,000 | 52,296,000 | 55,518,000 | 55,170,000 | 52,806,000 | 55,412,000 | 57,997,000 | |
| Shares (Diluted) | 50,301,000 | 49,662,000 | 49,860,000 | 50,525,000 | 51,427,000 | 52,765,000 | 55,927,000 | 56,476,000 | 54,852,000 | 56,097,000 | 59,057,000 | |
| EBITDA | $118M | $-82M | $119M | $183M | $310M | $332M | $344M | $324M | $346M | · | $316M |
Bilans 29
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $239M | $187M | $256M | $265M | $340M | $403M | $336M | $387M | $426M | $357M | $289M | |
| Short-term Investments | $1M | $11M | $12M | $14M | $15M | $21M | $8M | $11M | $12M | $11M | $14M | |
| Receivables | $40M | $51M | $59M | $47M | $41M | $63M | $50M | · | · | · | · | |
| Inventory | $179M | $190M | $280M | $346M | $400M | $314M | $276M | $296M | $253M | $250M | $265M | |
| Prepaid Expense | $90M | $73M | $81M | $88M | $77M | $102M | $70M | $52M | $53M | $65M | $102M | |
| Other Current Assets | $13M | $14M | $18M | $18M | $18M | $15M | $16M | $16M | $14M | $13M | $14M | |
| Current Assets | $548M | $539M | $702M | $760M | $873M | $903M | $740M | $799M | $778M | $714M | $706M | |
| PP&E (Net) | $377M | $380M | $433M | $445M | $454M | $468M | $454M | $465M | $465M | $445M | $455M | |
| PP&E (Gross) | $768M | $733M | $788M | $787M | $819M | $818M | $785M | $788M | $751M | $678M | $666M | |
| Accum. Depreciation | $391M | $353M | $355M | $342M | $366M | $350M | $331M | $323M | $286M | $234M | $212M | |
| Goodwill | $84M | $84M | $218M | $206M | $206M | $203M | $197M | $197M | $115M | $115M | $112M | |
| Intangibles | $43M | $74M | $95M | $67M | $77M | $90M | $80M | $90M | $68M | $64M | $67M | |
| Other Non-current Assets | $280M | $298M | $248M | $244M | $175M | $138M | $154M | $144M | $165M | $136M | $165M | |
| Total Assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B | |
| Accounts Payable | $26M | $35M | $43M | $54M | $50M | $66M | $39M | $48M | $50M | $41M | $29M | |
| Accrued Liabilities | $218M | $218M | $254M | $280M | $372M | $447M | $290M | $323M | $319M | $275M | $311M | |
| Current Liabilities | $264M | $297M | $329M | $359M | $530M | $543M | $357M | $440M | $447M | $399M | $408M | |
| Capital Leases | $58M | $58M | $71M | $77M | $89M | $112M | $106M | $0 | · | · | · | |
| Deferred Tax | $310.0K | $345.0K | $522.0K | $439.0K | $2M | $626.0K | $11M | $18M | $37M | $643.0K | $16M | |
| Other Non-current Liabilities | $75M | $97M | $107M | $110M | $106M | $102M | $97M | $112M | $127M | $77M | $91M | |
| Total Liabilities | $600M | $817M | $987M | $924M | $994M | $1.06B | $894M | $913M | $885M | $810M | $680M | |
| Long-term Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | $417M | $254M | |
| Total Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | · | $250M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $1.86B | $1.71B | $1.87B | $1.94B | $1.91B | $1.84B | $1.73B | $1.64B | $1.61B | $1.56B | $1.49B | |
| Treasury Stock | $1.58B | $1.56B | $1.57B | $1.57B | $1.53B | $1.46B | $1.32B | $1.33B | $1.30B | $1.25B | $1.02B | |
| AOCI | $-116M | $-125M | $-100M | $-87M | $-74M | $-65M | $-85M | $-80M | $-66M | $-84M | $-71M | |
| Stockholders' Equity | $805M | $651M | $822M | $897M | $913M | $894M | $875M | $782M | $705M | $664M | $826M | |
| Liabilities + Equity | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $52M | $70M | $71M | $73M | $76M | $74M | $77M | $83M | $72M | $72M | $71M | |
| Stock-based Comp | $24M | $15M | $16M | $12M | $23M | $24M | $10M | $27M | $19M | $9M | $7M | |
| Deferred Tax | $20.0K | $-55M | $-15M | $-51M | $6M | $-14M | $-288.0K | $-19M | $44M | $-181.0K | $21M | |
| Amort. of Intangibles | $7M | $12M | $12M | $10M | $12M | $10M | $13M | $18M | $8M | $8M | $9M | |
| Restructuring | · | · | · | · | · | · | $22M | $22M | · | · | · | |
| Other Non-cash | $-156M | $229M | $39M | $-30M | $-112M | $104M | $-82M | $-10M | $38M | · | $90M | |
| Operating Cash Flow | $80M | $112M | $119M | $108M | $142M | $379M | $178M | $203M | $303M | $275M | $322M | |
| CapEx | $34M | $42M | $58M | $59M | $69M | $64M | $66M | $70M | $60M | $50M | $57M | |
| Investing Cash Flow | $171M | $-38M | $-135M | $-67M | $-89M | $-79M | $-71M | $-109M | $-92M | $-58M | $-61M | |
| Debt Issued | $55M | $15M | $110M | $460M | $155M | $115M | $145M | $582M | $67M | $234M | $36M | |
| Net Debt Issued | $-170M | $-110M | $100M | $28M | $40M | $-28M | $-69M | $30M | $-36M | · | $36M | |
| Stock Repurchased | $20M | $0 | $13M | $70M | $80M | $144M | $825.0K | $70M | $72M | $247M | $164M | |
| Net Stock Activity | $-20M | $0 | $-13M | $-70M | $-80M | $-144M | $-825.0K | $-70M | $-72M | · | $-164M | |
| Dividends Paid | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | $78M | $81M | |
| Financing Cash Flow | $-202M | $-133M | $11M | $-100M | $-105M | $-245M | $-155M | $-117M | $-160M | $-135M | $-236M | |
| Net Change in Cash | $52M | $-69M | $-9M | $-75M | $-63M | $67M | $-51M | $-39M | $69M | $68M | $939.0K | |
| Taxes Paid | $41M | $30M | $32M | $42M | $96M | $56M | $98M | $123M | $78M | $123M | $50M | |
| Free Cash Flow | $46M | $70M | $60M | $49M | $73M | $315M | $112M | $132M | $242M | · | $265M | |
| Levered FCF | · | · | $52M | $33M | $66M | $306M | $99M | $120M | $232M | · | $261M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | · | · | |
| Operating Margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.1% | 9.0% | 12.0% | · | · | |
| Net Margin | 10.8% | -8.5% | 0.44% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | · | · | |
| Pretax Margin | 13.2% | -10.1% | 1.4% | 4.0% | 8.6% | 9.9% | 10.5% | 8.2% | 11.7% | · | · | |
| EBITDA Margin | 8.0% | -4.7% | 6.0% | 8.2% | 11.5% | 12.8% | 14.2% | 12.1% | 15.2% | · | · | |
| ROA | 11.2% | -8.9% | 0.47% | 5.6% | 7.6% | 10.3% | 10.0% | 7.4% | 8.5% | · | 8.5% | |
| ROE | 22.0% | -19.9% | 1.0% | 11.6% | 16.3% | 21.6% | 20.9% | 16.4% | 18.9% | · | 15.0% | |
| ROIC | 5.2% | -12.2% | 1.2% | 10.0% | 11.5% | 15.6% | 14.7% | 11.0% | 12.2% | · | 14.3% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 | 1.7 | 2.1 | 1.8 | 1.7 | · | 1.7 | |
| Quick Ratio | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 | 0.9 | 1.0 | 0.9 | 1.0 | · | 0.7 | |
| Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | · | 0.3 | |
| LT Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | 1.9 | 8.2 | 21.3 | 19.7 | 13.9 | 11.0 | 12.4 | · | 31.0 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.1 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.6 | 1.5 | · | · | |
| Inventory Turnover | 2.5 | 2.3 | 2.0 | 1.7 | 1.9 | 2.2 | 2.0 | 2.3 | 2.0 | · | 1.6 | |
| Receivables Turnover | 32.9 | 31.6 | 32.8 | 50.2 | 51.5 | 45.4 | · | · | · | · | · |
Stopy Wzrostu 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.6% | -13.7% | -8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -91.8% | -27.6% | -21.2% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 15.4% | · | -63.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.6% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -91.8% | -28.8% | -23.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 15.2% | · | -64.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -31.5% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 6
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | · | $2.25B | |
| Net Income TTM | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | · | $133M | |
| P/E | 3.0 | -2.3 | 114.2 | 20.4 | 17.7 | 15.0 | 13.2 | 28.4 | 28.9 | · | 16.8 | |
| Earnings Yield | 33.1% | -42.8% | 0.88% | 4.9% | 5.6% | 6.6% | 7.6% | 3.5% | 3.5% | · | 5.9% | |
| Payout Ratio | 7.4% | -8.1% | 903.1% | 73.5% | 51.8% | 41.0% | 47.4% | 66.1% | 58.8% | · | 61.0% | |
| Annual Payout | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | · | $81M |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $321M | $370M | $364M | $386M | $364M | $446M | $430M | $439M | $417M | $489M | $499M | $500M | $481M | $522M | $538M | |
| Cost of Revenue | $102M | $106M | $108M | $107M | $120M | $118M | $166M | $129M | $132M | $123M | $136M | $207M | $136M | $134M | $148M | $174M | |
| Gross Profit | $218M | $214M | $262M | $257M | $266M | $247M | $279M | $301M | $307M | $294M | $352M | $292M | $365M | $348M | $375M | $364M | |
| SG&A Expense | $91M | $99M | $107M | $105M | $107M | $113M | $121M | $116M | $118M | $125M | $145M | $131M | $137M | $134M | $128M | $138M | |
| Operating Expenses | $278M | $210M | $239M | $235M | $235M | $257M | $332M | $283M | $433M | $285M | $336M | $319M | $322M | $332M | $347M | $385M | |
| Operating Income | $-59M | $4M | $23M | $22M | $31M | $-10M | $-53M | $18M | $-126M | $9M | $16M | $-26M | $43M | $16M | $27M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $6M | $7M | $7M | · | $8M | $6M | $5M | · | · | |
| Other Non-op | $-534.0K | $3M | $-1M | $-2M | $-843.0K | $-28M | $1M | $2M | $629.0K | $-396.0K | $633.0K | $-551.0K | $376.0K | $3M | $10M | $-9M | |
| Pretax Income | $-63M | $3M | $18M | $16M | $27M | $135M | $-58M | $13M | $-132M | $1M | $9M | $-34M | $37M | $15M | $24M | $-29M | |
| Income Tax | $187M | $763.0K | $4M | $-1M | $6M | $27M | $-22M | $5M | $-13M | $2M | $2M | $3M | $10M | $3M | $-33M | $-4M | |
| Net Income | $-250M | $2M | $14M | $17M | $21M | $108M | $-36M | $8M | $-118M | $-533.0K | $7M | $-37M | $27M | $11M | $57M | $-25M | |
| EPS (Basic) | $-5.14 | $0.04 | $0.31 | $0.35 | $0.43 | $2.16 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | |
| EPS (Diluted) | $-5.14 | $0.04 | $0.27 | $0.34 | $0.43 | $2.14 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.15 | $-0.51 | |
| Shares (Basic) | 48,596,000 | 48,202,000 | -99,310,000 | 49,398,000 | 49,441,000 | 49,764,000 | -99,271,000 | 49,707,000 | 49,688,000 | 49,538,000 | -99,723,000 | 49,859,000 | 49,931,000 | 49,644,000 | -100,556,000 | 50,199,000 | |
| Shares (Diluted) | 48,596,000 | 49,422,000 | -99,836,000 | 50,310,000 | 49,499,000 | 50,328,000 | -99,297,000 | 49,733,000 | 49,688,000 | 49,538,000 | -100,218,000 | 49,859,000 | 50,161,000 | 50,058,000 | -101,700,000 | 50,199,000 | |
| EBITDA | $-47M | $16M | · | $34M | $44M | $4M | · | $36M | $-108M | $27M | · | $-8M | $60M | $33M | · | $-2M |
Bilans 29
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $190M | $199M | $239M | $252M | $264M | $204M | $187M | $228M | $224M | $213M | · | $233M | $236M | $230M | · | $294M | |
| Short-term Investments | $2M | $2M | $1M | $1M | $1M | $10M | $11M | $10M | $9M | $9M | · | $17M | $17M | $17M | · | $14M | |
| Receivables | $49M | $45M | $40M | $49M | $60M | $57M | $51M | $69M | $72M | $67M | · | $77M | $67M | $60M | · | $48M | |
| Inventory | $191M | $179M | $179M | $179M | $180M | $189M | $190M | $248M | $244M | $265M | · | $291M | $372M | $367M | · | $327M | |
| Prepaid Expense | $76M | $99M | $90M | $68M | $66M | $66M | $73M | $99M | $106M | $94M | · | $83M | $101M | $100M | · | $94M | |
| Other Current Assets | · | · | $13M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $508M | $523M | $548M | $548M | $572M | $525M | $539M | $653M | $654M | $647M | · | $701M | $793M | $774M | · | $778M | |
| PP&E (Net) | $380M | $382M | $377M | $375M | $374M | $380M | $380M | $411M | $412M | $423M | · | $429M | $430M | $438M | · | $433M | |
| PP&E (Gross) | · | · | $768M | · | · | · | $733M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $391M | · | · | · | $353M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $84M | $84M | $84M | $84M | $84M | $84M | $100M | $100M | $231M | · | $229M | $229M | $206M | · | $206M | |
| Intangibles | $38M | $39M | $43M | $44M | $46M | $48M | $74M | $85M | $88M | $102M | · | $109M | $113M | $65M | · | $69M | |
| Other Non-current Assets | $126M | $279M | $280M | $293M | $291M | $276M | $298M | $248M | $243M | $246M | · | $238M | $234M | $243M | · | $172M | |
| Total Assets | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B | |
| Accounts Payable | $38M | $29M | $26M | $29M | $29M | $34M | $35M | $33M | $36M | $32M | · | $49M | $50M | $49M | · | $42M | |
| Accrued Liabilities | $199M | $208M | $218M | $206M | $220M | $207M | $218M | $247M | $242M | $247M | · | $245M | $256M | $276M | · | $281M | |
| Current Liabilities | $256M | $257M | $264M | $254M | $284M | $260M | $297M | $339M | $309M | $309M | · | $434M | $445M | $373M | · | $366M | |
| Capital Leases | $50M | $54M | $58M | $62M | $62M | $62M | $58M | $68M | $70M | $74M | · | $68M | $74M | $79M | · | $78M | |
| Deferred Tax | · | · | $310.0K | · | · | · | $345.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $79M | $68M | $75M | $99M | $96M | $96M | $97M | $95M | $93M | $95M | · | $106M | $111M | $108M | · | $95M | |
| Total Liabilities | $579M | $583M | $600M | $625M | $656M | $637M | $817M | $876M | $900M | $932M | · | $971M | $998M | $932M | · | $921M | |
| Long-term Debt | $214M | $224M | $224M | $229M | $249M | $239M | $394M | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Total Debt | $214M | $224M | · | $229M | $249M | $239M | · | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | · | $91.0K | $91.0K | $91.0K | · | $91.0K | |
| Retained Earnings | $1.61B | $1.86B | $1.86B | $1.85B | $1.83B | $1.82B | $1.71B | $1.75B | $1.75B | $1.87B | · | $1.88B | $1.94B | $1.93B | · | $1.90B | |
| Treasury Stock | $1.56B | $1.56B | $1.58B | $1.57B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | · | $1.57B | $1.56B | $1.56B | · | $1.56B | |
| AOCI | $-118M | $-118M | $-116M | $-117M | $-114M | $-124M | $-125M | $-105M | $-117M | $-111M | · | $-109M | $-101M | $-91M | · | $-109M | |
| Stockholders' Equity | $543M | $794M | $805M | $800M | $788M | $754M | $651M | $707M | $686M | $810M | · | $822M | $895M | $893M | · | $842M | |
| Liabilities + Equity | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B |
Przepływy pieniężne 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $13M | $12M | $13M | $14M | $16M | $17M | $18M | $18M | $19M | $18M | $17M | $17M | $19M | $18M | |
| Stock-based Comp | $1M | $4M | $3M | $6M | $6M | $9M | $3M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Other Non-cash | · | $-22M | · | · | · | $-131M | · | · | · | $-19M | · | · | · | $-54M | · | · | |
| Operating Cash Flow | $11M | $-4M | $17M | $27M | $36M | $389.0K | $26M | $31M | $51M | $3M | $54M | $51M | $36M | $-22M | $26M | $28M | |
| CapEx | $6M | $14M | $11M | $10M | $18.0K | $14M | $13M | $9M | $8M | $12M | $20M | $12M | $15M | $11M | $14M | $25M | |
| Investing Cash Flow | $-6M | $-14M | $-10M | $-10M | $9M | $182M | $-14M | $-7M | $-9M | $-9M | $-15M | $-12M | $-93M | $-15M | $-13M | $-25M | |
| Debt Issued | $0 | $225M | $0 | $40M | $15M | $0 | $0 | $15M | $0 | $0 | $0 | $0 | $90M | $20M | $0 | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-155M | · | · | · | $-20M | · | · | · | $18M | · | · | |
| Stock Repurchased | $0 | $5M | $10M | $5M | $0 | $5M | $0 | $0 | $0 | $0 | $0 | $13M | $0 | $0 | $10M | $40M | |
| Net Stock Activity | · | $-5M | · | · | · | $-5M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $19M | $19M | $19M | $19M | $19M | $19M | |
| Financing Cash Flow | $-13M | $-20M | $-19M | $-27M | $9M | $-166M | $-44M | $-29M | $-29M | $-32M | $-20M | $-38M | $68M | $1M | $-51M | $-61M | |
| Net Change in Cash | $-9M | $-40M | $-13M | $-12M | $60M | $17M | $-41M | $4M | $12M | $-44M | $23M | $-2M | $6M | $-35M | $-29M | $-70M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-9M | · | · | · | $-34M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.2% | 66.9% | · | 70.5% | 68.8% | 67.8% | · | 70.1% | 70.0% | 70.5% | · | 58.6% | 72.9% | 72.2% | · | 67.7% | |
| Operating Margin | -18.5% | 1.3% | · | 5.9% | 8.0% | -2.7% | · | 4.2% | -28.6% | 2.1% | · | -5.3% | 8.5% | 3.3% | · | -3.8% | |
| Net Margin | -78.0% | 0.57% | · | 4.7% | 5.5% | 29.5% | · | 1.9% | -26.9% | -0.13% | · | -7.4% | 5.4% | 2.4% | · | -4.7% | |
| Pretax Margin | -19.7% | 0.81% | · | 4.4% | 7.1% | 36.9% | · | 3.1% | -30.0% | 0.26% | · | -6.9% | 7.4% | 3.0% | · | -5.4% | |
| EBITDA Margin | -14.6% | 5.1% | · | 9.3% | 11.3% | 1.2% | · | 8.3% | -24.6% | 6.5% | · | -1.6% | 11.9% | 6.9% | · | -0.39% | |
| ROA | -19.5% | 0.13% | · | 1.1% | 1.4% | 6.9% | · | 0.49% | -6.8% | -0.03% | · | -2.1% | 1.4% | 0.61% | · | -1.4% | |
| ROE | -37.5% | 0.24% | · | 2.3% | 2.9% | 13.8% | · | 1.1% | -15.0% | -0.06% | · | -4.4% | 2.9% | 1.2% | · | -2.9% | |
| ROIC | -31.0% | 0.28% | · | 2.2% | 2.3% | -0.80% | · | 1.0% | -9.8% | -0.33% | · | -2.1% | 2.2% | 0.95% | · | -1.4% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.0 | · | 2.2 | 2.0 | 2.0 | · | 1.9 | 2.1 | 2.1 | · | 1.6 | 1.8 | 2.1 | · | 2.1 | |
| Quick Ratio | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 1.0 | |
| Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.5 | 0.6 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | 2.8 | -18.7 | 1.2 | · | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 0.5 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 5.9 | 6.3 | · | 6.2 | 5.9 | 5.9 | · | 5.9 | 6.3 | 6.6 | · | 8.0 | 9.0 | 8.6 | · | 10.7 |
Wycena (TTM) 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.39B | $1.44B | · | $1.54B | $1.62B | $1.65B | · | $1.79B | $1.86B | $1.90B | · | $2.02B | $2.08B | $2.18B | · | $2.34B | |
| Net Income TTM | $-210M | $148M | · | $154M | $19M | $-3M | · | $-147M | $-129M | $780.0K | · | $-24M | $47M | $59M | · | $97M | |
| P/E | -1.2 | 2.5 | · | 4.0 | 22.2 | -90.8 | · | -2.5 | -4.1 | 691.5 | · | -44.2 | 35.7 | 34.2 | · | 17.7 | |
| Earnings Yield | -82.0% | 40.5% | · | 25.3% | 4.5% | -1.1% | · | -40.2% | -24.6% | 0.14% | · | -2.3% | 2.8% | 2.9% | · | 5.7% | |
| Payout Ratio | · | 156.5% | · | · | · | 2.8% | · | · | · | -558.9% | · | · | · | 170.5% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| Marża Brutto % | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% |
| Marża Operacyjna % | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| Zysk netto | $160M | $-147M | $9M | $105M | $147M |
| Rozwodniony EPS | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 |
| Wskaźnik bieżący | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 |
| Wskaźnik Szybkości | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $46M | $70M | $60M | $49M | $73M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- This $9 Nuclear Energy Stock Could Be Worth $100 by 2030
- Jedna trzecia ludzi uważa, że dyplom uniwersytecki nie jest wart zachodu, rozpoczyna się dochodzenie w sprawie pożyczek studenckich
- Jądro Atomowe to Energia 2026 Roku. Oto 2 Spółki, Które Warto Posadać Przez Cały Rok.
- NuScale Power vs. Oklo: Który z akcji nuklearnych jest lepszy do kupienia w 2026 roku?
- Oklo vs. NuScale Power w 2026 roku. Który z nich faktycznie warto kupić?
- 2 akcje energetyki jądrowej do kupienia w maju
- Prognoza: Akcje NuScale Power są warte zakupu przed 2027 rokiem dzięki tej okazji o wartości 1,75 biliona dolarów
- Najważniejsze punkty z rozmowy konferencyjnej dotyczącej wyników Nu Skin Enterprises za I kwartał
- NuScale Power spadł o 82%. Historia mówi, że ocaleni z takich awarii jak ta mogą wrócić 5x.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 188 emitentów · $157.3M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 34 (+13 vs poprzedni kw.) | 33 (+6 vs poprzedni kw.) | 51 (-14 vs poprzedni kw.) | 54 (-4 vs poprzedni kw.) | +4.8M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | $12 150 906 | 2 301 308 | 7,72% | Akcje |
| Coppell Advisory Solutions LLC | $11 266 612 | 235 | 7,16% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $10 822 104 | 2 049 641 | 6,88% | Akcje |
| Prescott Group Capital Management, L.L.C. | $9 475 530 | 1 794 608 | 6,02% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9 170 600 | 1 736 856 | 5,83% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $8 926 062 | 1 690 542 | 5,67% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $8 488 614 | 1 607 692 | 5,40% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7 671 507 | 1 452 937 | 4,88% | Akcje |
| CastleKnight Management LP | $7 337 262 | 1 389 633 | 4,66% | Akcje |
| TWO SIGMA ADVISERS, LP | $7 314 086 | 760 300 | 4,65% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $6 170 388 | 1 168 634 | 3,92% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $5 745 042 | 1 087 765 | 3,65% | Akcje |
| STATE STREET CORP | $5 330 941 | 1 009 648 | 3,39% | Akcje |
| PRUDENTIAL FINANCIAL INC | $3 959 403 | 749 887 | 2,52% | Akcje |
| CITADEL ADVISORS LLC | $3 337 140 | 632 034 | 2,12% | Akcje |
| Bank of New York Mellon Corp | $2 377 067 | 450 202 | 1,51% | Akcje |
| Allianz Asset Management GmbH | $2 074 074 | 392 817 | 1,32% | Akcje |
| D. E. Shaw & Co., Inc. | $1 795 385 | 340 035 | 1,14% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1 674 151 | 317 074 | 1,06% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 627 908 | 308 316 | 1,03% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $1 590 690 | 301 267 | 1,01% | Akcje |
| AXA Investment Managers S.A. | $1 307 268 | 107 241 | 0,83% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 287 735 | 243 889 | 0,82% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1 212 651 | 166 573 | 0,77% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 081 872 | 204 900 | 0,69% | Akcje |
| VANGUARD GROUP INC | $1 074 333 | 111 677 | 0,68% | Akcje |
| Vanguard Global Advisers, LLC | $936 603 | 177 387 | 0,60% | Akcje |
| FIRST TRUST ADVISORS LP | $925 594 | 175 302 | 0,59% | Akcje |
| XTX Topco Ltd | $823 379 | 155 943 | 0,52% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $803 590 | 152 195 | 0,51% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $799 852 | 151 487 | 0,51% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $728 614 | 137 995 | 0,46% | Akcje |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $670 856 | 127 056 | 0,43% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $628 125 | 118 963 | 0,40% | Akcje |
| ExodusPoint Capital Management, LP | $616 408 | 116 744 | 0,39% | Akcje |
| Cubist Systematic Strategies, LLC | $571 087 | 46 849 | 0,36% | Akcje |
| RITHOLTZ WEALTH MANAGEMENT | $527 566 | 99 918 | 0,34% | Akcje |
| STRS OHIO | $511 104 | 96 800 | 0,32% | Akcje |
| BlackRock, Inc. | $487 228 | 92 278 | 0,31% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $467 376 | 64 200 | 0,30% | Akcje |
| Nebula Research & Development LLC | $460 288 | 57 608 | 0,29% | Akcje |
| BANK OF AMERICA CORP /DE/ | $425 162 | 80 523 | 0,27% | Akcje |
| SummerHaven Investment Management, LLC | $402 215 | 76 177 | 0,26% | Akcje |
| EP Wealth Advisors, LLC | $387 314 | 73 355 | 0,25% | Akcje |
| BARCLAYS PLC | $375 540 | 71 125 | 0,24% | Akcje |
| Skopos Labs, Inc. | $373 217 | 51 266 | 0,24% | Akcje |
| Russell Investments Group, Ltd. | $372 662 | 70 580 | 0,24% | Akcje |
| RHUMBLINE ADVISERS | $332 444 | 62 965 | 0,21% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $326 631 | 61 862 | 0,21% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $323 110 | 61 195 | 0,21% | Akcje |
| Engineers Gate Manager LP | $314 688 | 59 600 | 0,20% | Akcje |
| Campbell & CO Investment Adviser LLC | $299 571 | 56 737 | 0,19% | Akcje |
| Graham Capital Management, L.P. | $297 649 | 56 373 | 0,19% | Akcje |
| Cambria Investment Management, L.P. | $283 969 | 53 782 | 0,18% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $281 276 | 53 272 | 0,18% | Akcje |
| FEDERATED HERMES, INC. | $276 213 | 52 313 | 0,18% | Akcje |
| WOLVERINE TRADING, LLC | $264 769 | 21 918 | 0,17% | Akcje |
| DGS Capital Management, LLC | $263 128 | 36 144 | 0,17% | Akcje |
| Quantinno Capital Management LP | $259 888 | 49 221 | 0,17% | Akcje |
| DEUTSCHE BANK AG\ | $251 391 | 47 612 | 0,16% | Akcje |
| Walleye Capital LLC | $248 947 | 47 149 | 0,16% | Akcje |
| CWM, LLC | $242 924 | 33 369 | 0,15% | Akcje |
| State of Tennessee, Department of Treasury | $227 648 | 43 115 | 0,14% | Akcje |
| AMERIPRISE FINANCIAL INC | $225 055 | 42 624 | 0,14% | Akcje |
| Aquatic Capital Management LLC | $223 634 | 42 355 | 0,14% | Akcje |
| MANGROVE PARTNERS IM, LLC | $222 198 | 42 083 | 0,14% | Akcje |
| WELLS FARGO & COMPANY/MN | $215 783 | 40 868 | 0,14% | Akcje |
| Verdad Advisers, LP | $195 355 | 36 999 | 0,12% | Akcje |
| FMR LLC | $173 791 | 32 915 | 0,11% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $172 767 | 32 721 | 0,11% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $170 544 | 32 300 | 0,11% | Akcje |
| Range Financial Group LLC | $167 666 | 31 755 | 0,11% | Akcje |
| State of Wyoming | $161 019 | 30 496 | 0,10% | Akcje |
| Abel Hall, LLC | $149 112 | 28 241 | 0,09% | Akcje |
| Empowered Funds, LLC | $146 351 | 27 718 | 0,09% | Akcje |
| WOLVERINE TRADING, LLC | $143 752 | 11 900 | 0,09% | Opcja sprzedaży |
| MetLife Investment Management, LLC | $140 765 | 26 660 | 0,09% | Akcje |
| Atom Investors LP | $140 078 | 26 530 | 0,09% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $139 561 | 26 432 | 0,09% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $131 604 | 24 925 | 0,08% | Akcje |
| HSBC HOLDINGS PLC | $127 773 | 24 619 | 0,08% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $121 567 | 23 024 | 0,08% | Akcje |
| Vanguard Personalized Indexing Management, LLC | $120 410 | 22 805 | 0,08% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $118 642 | 22 470 | 0,08% | Akcje |
| Creative Planning | $116 686 | 22 100 | 0,07% | Akcje |
| Advisors Asset Management, Inc. | $115 366 | 16 744 | 0,07% | Akcje |
| Aigen Investment Management, LP | $104 137 | 19 723 | 0,07% | Akcje |
| CITIGROUP INC | $103 889 | 19 676 | 0,07% | Akcje |
| Invesco Ltd. | $102 585 | 19 429 | 0,07% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $100 848 | 19 100 | 0,06% | Opcja sprzedaży |
| GLENMEDE TRUST CO NA | $100 541 | 19 042 | 0,06% | Akcje |
| CITADEL ADVISORS LLC | $98 736 | 18 700 | 0,06% | Opcja sprzedaży |
| AlphaQuest LLC | $95 748 | 9 953 | 0,06% | Akcje |
| Schonfeld Strategic Advisors LLC | $78 908 | 14 945 | 0,05% | Akcje |
| Jain Global LLC | $76 032 | 14 400 | 0,05% | Akcje |
| MEEDER ASSET MANAGEMENT INC | $72 975 | 13 821 | 0,05% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $72 695 | 13 768 | 0,05% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $72 107 | 13 787 | 0,05% | Akcje |
| BANK OF MONTREAL /CAN/ | $70 504 | 13 353 | 0,04% | Akcje |
| PharVision Advisers, LLC | $69 707 | 13 202 | 0,04% | Akcje |
Insiderzy spółki 57 insiderów · 31 dyrektorzy generalni · 25 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ryan S Napierski | President and CEO | 6 marca 2026 A | 1 001 905 | 0 | 0 | $0 |
| Ritch N Wood | Chief Executive Officer | 17 czerwca 2021 S | 175 239 | 0 | 0 | $0 |
| Truman M Hunt | President & CEO | 27 lutego 2017 A | 575 559 | 0 | 0 | $0 |
| James D Thomas | Chief Financial Officer | 6 marca 2026 A | 267 102 | 0 | 0 | $0 |
| Mark H Lawrence | Chief Financial Officer | 2 marca 2023 M | 57 146 | 0 | 0 | $0 |
| Scott E Schwerdt | President, Americas Region | 18 grudnia 2015 A | 34 585 | 0 | 0 | $0 |
| Gary Sumihiro | President | 20 grudnia 2007 A | 800 | 0 | 0 | $0 |
| Luke Loo | President | 20 grudnia 2007 A | 5 625 | 0 | 0 | $0 |
| Larry V Macfarlane | President, Big Planet | 26 lutego 2007 A | 6 005 | 0 | 0 | $0 |
| Robert S Conlee | President, North Asia & Japan | 26 lutego 2007 A | 4 549 | 0 | 0 | $0 |
| Lori H Bush | President -Nu Skin Division | 31 sierpnia 2005 A | 11 453 | 0 | 0 | $0 |
| Chayce David Clark | EVP, COO and CLO | 6 marca 2026 A | 390 746 | 0 | 1 | $-239 400 |
| Justin S Keisel | EVP, President of Global Sales | 6 marca 2026 A | 160 170 | 0 | 0 | $0 |
| Steven Keith Hatchett | Chief Product Officer | 6 marca 2026 A | 260 818 | 1 | 0 | $52 855 |
| Connie Mang Yee Tang | Chief Global Growth Officer | 21 kwietnia 2023 F | 43 204 | 0 | 0 | $0 |
| Joseph Y Chang | Chief Scientific Officer | 2 marca 2023 M | 21 234 | 0 | 0 | $0 |
| Steven Lund | Exec. Chairman of the Board | 1 marca 2023 G | 113 574 | 0 | 0 | $0 |
| Jeffrey Clark Bettinger | SVP, People and Places Officer | 5 października 2021 S | 16 068 | 0 | 0 | $0 |
| Matthew D Dorny | General Counsel | 2 lipca 2021 M | 47 159 | 0 | 0 | $0 |
| Daniel R Chard | Pres Global Sales & Operations | 6 lipca 2015 M | 48 111 | 0 | 0 | $0 |
| Blake Roney | Chairman of the Board | 3 czerwca 2011 G | 3 216 458 | 0 | 0 | $0 |
| Ashok Pahwa | Chief Marketing Officer | 28 sierpnia 2009 F | 3 322 | 0 | 0 | $0 |
| Jack Peterson | Vice President | 20 grudnia 2007 A | 6 984 | 0 | 0 | $0 |
| Mark L Adams | Chief Information Officer | 20 grudnia 2007 A | 11 410 | 0 | 0 | $0 |
| Claire Averett | Vice President | 4 września 2007 F | 3 230 | 0 | 0 | $0 |
| Brett Nelson | Vice President | 4 września 2007 F | 4 202 | 0 | 0 | $0 |
| Corey B Lindley | Executive Vice President | 1 września 2006 A | 20 750 | 0 | 0 | $0 |
| Mark Wolfert | Regional Vice President- | 31 sierpnia 2005 A | 0 | 0 | 0 | $0 |
| Michael D Smith | Vice President-Gov't Relations | 31 sierpnia 2005 A | 1 734 | 0 | 0 | $0 |
| Richard W King | Chief Information Officer | 31 sierpnia 2005 A | 5 987 | 0 | 0 | $0 |
| Brooke Roney | Senior Vice President | 2 grudnia 2004 G | 825 000 | 0 | 0 | $0 |
| Edwina D Woodbury | Dyrektor | 10 czerwca 2026 A | 62 452 | 0 | 1 | $-41 057 |
| James M Winett | Dyrektor | 2 czerwca 2026 S | 37 448 | 0 | 1 | $-40 481 |
| Laura Nathanson | Dyrektor | 1 czerwca 2026 A | 57 116 | 0 | 2 | $-97 305 |
| Emma S. Battle | Dyrektor | 1 czerwca 2026 A | 57 648 | 0 | 0 | $0 |
| Pisano R. Thomas | Dyrektor | 1 czerwca 2026 A | 116 827 | 0 | 0 | $0 |
| Mark A Zorko | Dyrektor | 1 czerwca 2026 A | 60 586 | 0 | 0 | $0 |
| Daniel W Campbell | Dyrektor | 1 czerwca 2026 A | 65 859 | 0 | 2 | $-392 669 |
| Zheqing Shen | Dyrektor | 7 czerwca 2024 A | 33 195 | 0 | 0 | $0 |
| Andrew D Lipman | Dyrektor | 28 maja 2024 S | 23 225 | 0 | 0 | $0 |
| Neil H Offen | Dyrektor | 21 maja 2019 M | 10 083 | 0 | 0 | $0 |
| Nevin N Andersen | Dyrektor | 21 maja 2019 M | 34 045 | 0 | 0 | $0 |
| Zhequing Shen | Dyrektor | 11 maja 2017 A | 3 456 | 0 | 0 | $0 |
| Patricia Negron | Dyrektor | 13 maja 2015 G | 7 592 | 0 | 0 | $0 |
| Sandra Tillotson | Dyrektor | 4 maja 2012 M | 1 885 845 | 0 | 0 | $0 |
| David D. Ussery | Dyrektor | 9 lutego 2012 M | 13 222 | 0 | 0 | $0 |
| Ej Jake Garn | Dyrektor | 24 maja 2011 A | 17 272 | 0 | 0 | $0 |
| Desmond C Wong | Dyrektor | 15 maja 2007 A | 1 400 | 0 | 0 | $0 |
| Christine Mccormick Day | Dyrektor | 15 maja 2007 A | 1 400 | 0 | 0 | $0 |
| Allen D Andersen | Dyrektor | 25 maja 2006 A | 2 500 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 11 lutego 2008 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 2 kwietnia 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 26 marca 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 15 marca 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 8 grudnia 2006 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 9 czerwca 2006 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 8 maja 2006 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 20 stycznia 2006 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 15 grudnia 2005 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 47 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| DEEP · ETF Series Solutions | 0,71% | 32 178 NS | 31 maja 2026 | N-PORT |
| MYLD · Cambria ETF Trust | 0,62% | 25 194 NS | 30 kwietnia 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,37% | 62 972 NS | 31 maja 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,37% | 103 377 NS | 31 maja 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 113 111 NS | 30 kwietnia 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 123 628 SH | 8 sierpnia 2026 | Dziennie |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 1 220 658 NS | 31 maja 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,06% | 51 988 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,06% | 164 733 SH | 8 sierpnia 2026 | Dziennie |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,04% | 1 939 936 NS | 31 maja 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 63 063 NS | 31 maja 2026 | N-PORT |
| VDC · VANGUARD WORLD FUND | 0,03% | 570 468 SH | 8 sierpnia 2026 | Dziennie |
| EBIT · Harbor ETF Trust | 0,03% | 435 NS | 30 kwietnia 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,02% | 242 807 NS | 30 kwietnia 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 42 579 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 90 212 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 492 546 SH | 8 sierpnia 2026 | Dziennie |
| DFAT · Dimensional ETF Trust | 0,01% | 253 656 NS | 30 kwietnia 2026 | N-PORT |
| SMLF · iShares Trust | 0,01% | 108 807 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 20 906 NS | 30 kwietnia 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 280 867 SH | 8 sierpnia 2026 | Dziennie |
| SFGV · EA Series Trust | 0,01% | 27 758 NS | 29 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1 306 883 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 161 524 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2 272 NS | 31 maja 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 13 837 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 236 168 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 776 NS | 31 maja 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1 999 NS | 30 kwietnia 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 797 NS | 31 maja 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 33 427 SH | 8 sierpnia 2026 | Dziennie |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 38 038 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 714 NS | 31 maja 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 1 031 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 45 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 155 NS | 30 kwietnia 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2 509 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10 479 NS | 30 kwietnia 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69 546 SH | 8 sierpnia 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 27 870 NS | 31 maja 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12 071 SH | 8 sierpnia 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 6 548 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 562 165 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 465 550 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 734 SH | 8 sierpnia 2026 | Dziennie |
| EBI · RBB Fund Trust | 0,00% | 3 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1 362 NS | 30 kwietnia 2026 | N-PORT |